RA Capital Nexus Fund II, L.P.

Director, 10% OwnerDICE Therapeutics, Inc. (DICE) · full profile →Form 4 · filed Mar 30, 2023
Net Buying
Open-Market Buys
$14.8M
Open-Market Sells
$0
Net Open-Market Flow
$14.8M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2023Buy(P)196K$28.74$5.6M7.1M
Mar 29, 2023Buy(P)66K$29.38$1.9M6.9M
Mar 28, 2023Buy(P)247K$29.24$7.2M6.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-039250) within minutes of acceptance. Every field above traces to the original document. Verify it directly: